Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Total Liabilities (2020 - 2025)

Historic Total Liabilities for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $88.7 million.

  • NeuroPace's Total Liabilities rose 260.99% to $88.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.7 million, marking a year-over-year increase of 260.99%. This contributed to the annual value of $86.6 million for FY2024, which is 41.73% down from last year.
  • NeuroPace's Total Liabilities amounted to $88.7 million in Q3 2025, which was up 260.99% from $86.7 million recorded in Q2 2025.
  • Over the past 5 years, NeuroPace's Total Liabilities peaked at $88.7 million during Q3 2025, and registered a low of $58.3 million during Q2 2021.
  • Over the past 5 years, NeuroPace's median Total Liabilities value was $81.0 million (recorded in 2023), while the average stood at $77.1 million.
  • In the last 5 years, NeuroPace's Total Liabilities crashed by 5959.35% in 2021 and then surged by 3208.51% in 2022.
  • Quarter analysis of 5 years shows NeuroPace's Total Liabilities stood at $60.1 million in 2021, then soared by 32.09% to $79.3 million in 2022, then grew by 9.67% to $87.0 million in 2023, then dropped by 0.42% to $86.6 million in 2024, then rose by 2.43% to $88.7 million in 2025.
  • Its Total Liabilities was $88.7 million in Q3 2025, compared to $86.7 million in Q2 2025 and $85.9 million in Q1 2025.